These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23320495)

  • 1. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Keil SD; Kiser P; Sullivan JJ; Kong AS; Reddy HL; Avery A; Goodrich RP
    Transfusion; 2013 Oct; 53(10):2278-86. PubMed ID: 23320495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation.
    El Chaar M; Atwal S; Freimanis GL; Dinko B; Sutherland CJ; Allain JP
    Transfusion; 2013 Dec; 53(12):3174-83. PubMed ID: 23656538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
    Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
    Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ; Rentas FJ; Ketchum L; Salata J; Harman R; Melvin W; Weina PJ; Mendez J; Reddy H; Goodrich R
    Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ; Salata J; Mendez J; Reddy H; Goodrich R
    Transfus Apher Sci; 2007 Oct; 37(2):131-7. PubMed ID: 17950672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
    Tonnetti L; Proctor MC; Reddy HL; Goodrich RP; Leiby DA
    Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
    Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
    Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
    Ambruso DR; Thurman G; Marschner S; Goodrich RP
    Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.
    Keil SD; Bengrine A; Bowen R; Marschner S; Hovenga N; Rouse L; Gilmour D; Duverlie G; Goodrich RP
    Transfusion; 2015 Jul; 55(7):1736-44. PubMed ID: 25731607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage.
    Owusu-Ofori S; Kusi J; Owusu-Ofori A; Freimanis G; Olver C; Martinez CR; Wilkinson S; Mundt JM; Keil SD; Goodrich RP; Allain JP
    Shock; 2015 Aug; 44 Suppl 1(Suppl 1):33-8. PubMed ID: 25423125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage.
    Schubert P; Culibrk B; Coupland D; Scammell K; Gyongyossy-Issa M; Devine DV
    Transfusion; 2012 Feb; 52(2):397-408. PubMed ID: 21827504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model.
    Chi X; Zhi L; Vostal JG
    Transfusion; 2014 Jan; 54(1):74-85. PubMed ID: 23656563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment.
    Schubert P; Coupland D; Culibrk B; Goodrich RP; Devine DV
    Transfusion; 2013 Dec; 53(12):3164-73. PubMed ID: 23521225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
    Goodrich RP; Murthy KK; Doane SK; Fitzpatrick CN; Morrow LS; Arndt PA; Reddy HL; Buytaert-Hoefen KA; Garratty G
    Transfusion; 2009 Jan; 49(1):64-74. PubMed ID: 18954398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
    Ruane PH; Edrich R; Gampp D; Keil SD; Leonard RL; Goodrich RP
    Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model.
    Rentas F; Harman R; Gomez C; Salata J; Childs J; Silva T; Lippert L; Montgomery J; Richards A; Chan C; Jiang J; Reddy H; Li J; Goodrich R
    Transfusion; 2007 Feb; 47(2):240-7. PubMed ID: 17302769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
    Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
    Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
    Keil SD; Ragan I; Yonemura S; Hartson L; Dart NK; Bowen R
    Vox Sang; 2020 Aug; 115(6):495-501. PubMed ID: 32311760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets.
    Castro E; González LM; Rubio JM; Ramiro R; Gironés N; Montero E
    Transfusion; 2014 Sep; 54(9):2207-16. PubMed ID: 24666393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.